ArticleFrontiers in psychology2025
Global, regional, and national burden and trends of depressive disorders among women of childbearing age from 1990 to 2021: insights from GBD 2021.
Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Ultrasound in Women's Health: Mechanisms, Applications, and Emerging Opportunities.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Ceramides and neuroinflammation as immunometabolic drivers and biomarkers of major depressive disorder, treatment-resistant depression, and suicidal vulnerability.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depressive disorders are highly prevalent and disabling mental illnesses among women of childbearing age (WCBA), especially with the surge in prevalence following the COVID-19 pandemic, but evidence on their burden remains insufficient. This study provides a thorough analysis of the burden of depressive disorders among WCBA at global, regional and national levels. Methods: This study utilized data from Global burden of disease (GBD) 2021 to evaluate the trends in incidence, prevalence, Disability-Adjusted Life Years (DALYs) of depressive disorders among WCBA from 1990 to 2021. Data was stratified by time, age, region, and socio-demographic index (SDI). Moreover, this study utilized a range of analytical methods, including estimated annual percentage change (EAPC), Joinpoint regression, decomposition analysis and predictive modeling (Nordpred method). Results: Depressive disorders in WCBA constitute a growing global health crisis, marked by a notable rise in absolute cases, accompanied by a slight downward age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized DALYs rate (ASDALYR). In 2021, there were 133.25 million incident cases, 121.24 million prevalent cases, and 21.04 million DALYs. In 2021, the global ASIR, ASPR, and ASDALYR were 6,808.01 (95% uncertainty interval [UI]: 5,049.99 to 9,106.66) per 100,000, 6173.45 (95% UI: 4,883.27 to 7,781.73) per 100,000, and 1,073.50 (95% UI: 686.73 to 1,562.48) per 100,000. High SDI region had the highest ASIR, ASPR, and ASDALYR. Furthermore, High-income North America exhibited the highest ASIR, ASPR and ASDALYR. Joinpoint regression analysis yielded a pronounced increase in ASIR subsequent to 2019. Nordpred predictive model demonstrated an upward trend in the ASIR, ASPR and ASDALYR of depressive disorders among WCBA by 2046. Conclusion: Depressive disorders among WCBA show a globally rising burden, particularly in high SDI region, with a notable post-2019 increase. This underscores an urgent need for tailored public health action alleviate the growing mental health burden, particularly among WCBA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.